Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country

Abstract

Get full access to this article

View all access options for this article.

References

Woolley

Bailey

. Visiting friends and relatives may be a risk for non-adherence for HIV-positive travellers. Int J STD AIDS 2012; 23: 833–834.

Sellier

Clevenbergh

Ljubicic

. Comparative evaluation of adherence to antiretroviral therapy in Sub-Saharan African Native HIV-infected patients in France and Africa. Clin Infect Dis 2006; 43: 654–657.

Sumari-De BI, Sprangers MA, Prins JM, et al. HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients. AIDS Behav 2012;1681–1689.

Marcellin

Carrieri

Peretti-Watel

the VESPA study group . Do migrants overreport adherence to highly antiretroviral therapies: results from the French VESPA (ANRS-EN12) national survey. J Acquir Immune Defic Syndr 2006; 42: 646–764.

Lert F, Annequin M, Tron L; et le groupe Vespa2. Socioeconomic conditions of people living with HIV followed at hospital in metropolitan France. Results of the ANRS-VESPA2 study. BEH 26–27:293–299, http://www.invs.sante.fr/beh/2013/27/pdf/2013_26–27.pdf (2013, accessed 14 September 2013).

Carrieri

Raffi

Lewden

. APROCO study group. Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antiviral Ther 2003; 8: 585–594.